Use of the antimicrobial peptide LL37 for immunotherapy of melanoma

被引：0
|
作者：
Demaria, O. [1 ]
Singh, M. [2 ]
Conrad, C. [1 ]
Gilliet, M. [1 ]
机构：
[1] CHU Vaudois, CH-1011 Lausanne, Switzerland
[2] MD Anderson Canc Inst, Houston, TX USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2012年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
719
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [41] Antimicrobial peptide LL37 promotes vascular endothelial growth factor-A expression in human periodontal ligament cells
    Kittaka, M.
    Shiba, H.
    Kajiya, M.
    Ouhara, K.
    Takeda, K.
    Kanbara, K.
    Fujita, T.
    Kawaguchi, H.
    Komatsuzawa, H.
    Kurihara, H.
    JOURNAL OF PERIODONTAL RESEARCH, 2013, 48 (02) : 228 - 234
  • [42] Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury
    Zhang, Ling-juan
    Sen, George L.
    Ward, Nicole L.
    Johnston, Andrew
    Chun, Kimberly
    Chen, Yifang
    Adase, Christopher
    Sanford, James A.
    Gao, Nina
    Chensee, Melanie
    Sato, Emi
    Fritz, Yi
    Baliwag, Jaymie
    Williams, Michael R.
    Hata, Tissa
    Gallo, Richard L.
    IMMUNITY, 2016, 45 (01) : 119 - 130
  • [43] Antimicrobial peptide LL37 and regulatory T cell associated with late-onset sepsis in very preterm infants
    Zhuxiao, Ren
    Shuo, Yang
    Jiangxue, Han
    Jingjun, Pei
    Qi, Zhang
    Zhu, Wang
    Fang, Xu
    Jie, Yang
    ISCIENCE, 2024, 27 (05)
  • [44] Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
    Lande, Roberto
    Palazzo, Raffaella
    Hammel, Philippe
    Pietraforte, Immacolata
    Surbeck, Isabelle
    Gilliet, Michel
    Chizzolini, Carlo
    Frasca, Loredana
    ANTIBODIES, 2020, 9 (02)
  • [45] Antimicrobial peptide LL-37 in human atherosclerosis
    Edfeldt, K.
    Agerberth, B.
    Rottenberg, M. E.
    Gudmundsson, G. H.
    Mandal, K.
    Xu, Q. B.
    Hansson, G. K.
    Yan, Z. Q.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 407 - 407
  • [46] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Bucki, Robert
    Leszczynska, Katarzyna
    Namiot, Andrzej
    Sokolowski, Wojciech
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (01) : 15 - 25
  • [47] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Robert Bucki
    Katarzyna Leszczyńska
    Andrzej Namiot
    Wojciech Sokołowski
    Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 : 15 - 25
  • [48] Interaction of Antimicrobial Peptide Ll-37 with Lipopolysaccharides
    Martynowycz, Michael
    Rice, Amy
    Andreev, Konstantin
    Pavinatto, Thatyane M. Nobre
    Wereszczynski, Jeff
    Gidalevitz, David
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 45A - 45A
  • [49] Antimicrobial peptide LL37 is potent against non-growing Escherichia coli cells despite a slower action rate
    Mohammadi, Salimeh
    Saucedo, Derek
    Taheri-Araghi, Sattar
    MSPHERE, 2025, 10 (01)
  • [50] The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation
    Salamah, Maryam F.
    Ravishankar, Divyashree
    Kodji, Xenia
    Moraes, Leonardo A.
    Williams, Harry F.
    Vallance, Thomas M.
    Albadawi, Dina A.
    Vaiyapuri, Rajendran
    Watson, Kim
    Gibbins, Jonathan M.
    Brain, Susan D.
    Perretti, Mauro
    Vaiyapuri, Sakthivel
    BLOOD ADVANCES, 2018, 2 (21) : 2973 - 2985
12345